(Q53292171)

13 May 2018

title

Initial experience with factor-Xa inhibition in percutaneous coronary intervention: the XaNADU-PCI Pilot. (English)

1 reference

13 May 2018

author

Judith S Hochman

8

1 reference

13 May 2018

Paul W. Armstrong

21

1 reference

13 May 2018

A Michael Lincoff

11

object named as

A M Lincoff

1 reference

13 May 2018

J H Alexander

1

1 reference

13 May 2018

C K Dyke

2

1 reference

13 May 2018

H Yang

3

1 reference

13 May 2018

R C Becker

4

1 reference

13 May 2018

V Hasselblad

5

1 reference

13 May 2018

L A Zillman

6

1 reference

13 May 2018

N S Kleiman

7

1 reference

13 May 2018

P B Berger

9

1 reference

13 May 2018

E A Cohen

10

1 reference

13 May 2018

H Saint-Jacques

12

1 reference

13 May 2018

S Chetcuti

13

1 reference

13 May 2018

J R Burton

14

1 reference

13 May 2018

J M Buergler

15

1 reference

13 May 2018

F P Spence

16

1 reference

13 May 2018

Y Shimoto

17

1 reference

13 May 2018

T L Robertson

18

1 reference

13 May 2018

S Kunitada

19

1 reference

13 May 2018

E G Bovill

20

1 reference

13 May 2018

R A Harrington

22

1 reference

13 May 2018

XaNADU-PCI PILOT Investigators

23

1 reference

13 May 2018

publication date

1 February 2004

1 reference

13 May 2018

Journal of Thrombosis and Haemostasis

published in

1 reference

13 May 2018

volume

2

1 reference

13 May 2018

issue

2

1 reference

13 May 2018

page(s)

234-241

1 reference

13 May 2018

Antithrombotic therapy in patients undergoing percutaneous coronary intervention

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7933.2004.00594.X

Low-molecular-weight heparin : A review of the results of recent studies of the treatment of venous thromboembolism and unstable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7933.2004.00594.X

Use of low-molecular-weight heparins in the management of acute coronary artery syndromes and percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7933.2004.00594.X

A synthetic pentasaccharide for the prevention of deep-vein thrombosis after total hip replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7933.2004.00594.X

A synthetic factor-Xa inhibitor (ORG31540/SR9017A) as an adjunct to fibrinolysis in acute myocardial infarction. The PENTALYSE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7933.2004.00594.X

First experience with direct factor Xa inhibition in patients with stable coronary disease: a pharmacokinetic and pharmacodynamic evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7933.2004.00594.X

Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7933.2004.00594.X

Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7933.2004.00594.X

Applications of monitoring platelet glycoprotein IIb/IIIa antagonism and low molecular weight heparins in cardiovascular medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7933.2004.00594.X

Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7933.2004.00594.X

Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7933.2004.00594.X

Low–molecular-weight heparin therapy for non-ST-elevation acute coronary syndromes and during percutaneous coronary intervention: An expert consensus*

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7933.2004.00594.X

10.1111/J.1538-7933.2004.00594.X

21 January 2018

Identifiers

DOI

1 reference

13 May 2018

PubMed ID

14995984

1 reference

13 May 2018